About the Database System

      The European Union (EU) has mandated its member states and the countries of the European Economic Area (EEA) to implement verification for certain medicines through a Europe-wide interconnected database system.

      Since February 9, 2019, strict requirements have been in force in the EU: all prescription-only human medicines must be equipped with safety features. These features ensure the uniqueness of a medicine pack and prevent counterfeit medicines from entering the legal supply chain. The verification of these safety features is carried out by scanning a Datamatrix code at dispensing points, such as pharmacies, medical practices with in-house pharmacies, or hospitals, before the medicine is dispensed.

      For this purpose, national database systems (National Medicines Verification Systems, NMVSs) must be set up in each participating country. The national database systems are connected to the EU Hub managed by the European Medicines Verification Organisation (EMVO), creating an interconnected network.

      Slider E Architektur 1Figure: System architecture and data flows of the pan-European system (EU Hub and National Systems)


      The EMVO, as well as the National Medicines Verification Organisations (NMVOs), are established as private, non-profit organizations.

      As an operational organization, SMVO founded the "SMVS Swiss Medicines Verification Organisation GmbH" (SMVS GmbH). SMVS provides services related to the national database system (NMVS) to all affected parties and organisations in Switzerland and Liechtenstein.

      System status

      • All affected EU and EEA member countries are connected to the productive system of the EU Hub.
      • The CH-LIE system has been operational since February 15, 2019, and is connected to the EU Hub.
      • End users can register with the NMVS and use the system.
      • Software providers can connect their solutions to the NMVS.
      • Marketing Authorization Holders (MAHs) can upload data for the target market "CH" if they have signed a contract with SMVS GmbH.
      • For further information on the European system, please visit www.emvo-medicines.eu.

      >> Using the Databse System

      We use cookies

      We use session cookies to make our website work, but we do not use tracking cookies. You can decide for yourself whether you want to allow cookies. Please note that if you reject them, not all of the site's functionalities may be available.